A naukri.com initiative
Bloomberg Quint
1d
360
Image Credit: Bloomberg Quint
Stocks To Buy Today: ITC, Devyani International, Sun Pharma, Alkem Labs And More
- Angel One's Singh has recommended buying Star Cement stock at Rs 230 to Rs 232 per share, with a price target at Rs 269. The stop loss for the stock should be at Rs 209. The stock has risen by 37.01% in the past 12 months and crossed over 33.35% in this year to date period.
- SBICAP Securities' Sudeep Shah has suggested buying Amber Enterprises India at Rs 6,900 with a target of Rs 7,150, keeping the stop loss at Rs 6,760. Amber Enterprises share price has risen 127.14% in the past 12 months, and 122.38% year-to-date.
- Shah also has a buy call on pharmaceutical company Jubilant Ingrevia at Rs 800, with a target price of Rs 845. Stop loss for the counter should be pegged at Rs 780.
- Nilesh Jain recommends buying Devyani International stock with the target at Rs 184 and keeping the stop loss at Rs 173. The scrip has fallen 6.49% in the past 12 months.
- Alkem Labs stock has received a 'buy' call from Angel One's Singh. The market expert recommends buying the stock at a price of Rs 5,450, with the target at Rs 5,667 per share and stop loss at Rs 5,337.
- Aditya Arora from Adlytick.in has a buy call on ITC at Rs 474, with a target price of Rs 490. Stop loss for the counter should be pegged at Rs 558. The stock has given 4.04% returns in the past 12 months.
- Arora also recommends buying Sun Pharma stock at Rs 1,815 with the target at Rs 1,865 and then Rs 1,875. He calls for keeping the stop loss at Rs 1,760. The scrip has risen 45.48% in the past 12 months.
- Buy recommendations have been made for ITC Ltd., Devyani International Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., and more. These stocks could see an upside of as much as 14% from current levels.
- Of the 23 analysts tracking Alkem Labs stock, 10 recommend 'buy', eight 'hold' and five 'sell'. The consensus 12-month analysts' price target for the share is Rs 5,720.32, implying an upside potential of 4.3%.
- Of the 38 analysts tracking ITC stock, 33 recommend 'buy', three 'hold' and two 'sell'. The consensus 12-month price target for the share is Rs 539.49, implying an upside potential of 13.8%.
Read Full Article
21 Likes
For uninterrupted reading, download the app